Research investigates hexadecanamide's properties and binding affinity in therapeutic applications, suggesting potential bioactivity.
Hexadecanamide (HDA), a long-chain fatty acid amide, was identified as a key bioactive constituent in the extract of Aegle marmelos using GC-MS analysis and chosen for further theoretical and biological studies. Density functional theory (DFT) was used to examine the molecular structure and vibrational properties of HDA at the B3LYP/6-311++G(d,p) level. The computed results were compared with the experimental FT-IR and UV-visible spectra. The structural stability of the molecule was confirmed by the optimized geometrical parameters, which showed good agreement with the available experimental data. To comprehend the chemical reactivity and stability of HDA, the electronic properties, such as HOMO–LUMO energies, energy gap, chemical hardness, softness, and electrophilicity index, were assessed. Charge delocalization and intramolecular interactions were examined using Natural Bond Orbital (NBO) analysis, and electrophilic and nucleophilic reactive sites were identified using the Molecular Electrostatic Potential (MEP) surface. The theoretical and experimental UV-Vis absorption bands correlated well, according to TD-DFT calculations. The binding affinity of HDA with the target protein was further investigated by molecular docking studies, which revealed advantageous interactions through hydrophobic and hydrogen bonding contacts. HDA's potential as a bioactive therapeutic candidate is supported by the combined experimental and computational results, which indicate that it has strong structural stability and encouraging biological activity.
No takes yet. Share an insight, caveat, or question.
Revathi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: